KMS Medisurgi Ltd.
Snapshot View

69.65 ▼0%

16 January 2023, 04:01:00 PM

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.kmsgroup.in
Market Cap 22.98 Cr.
Enterprise Value(EV) 23.56 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 0.65 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 106.90 Trailing Twelve Months Ending 2022-03
Industry PE 54.40 Trailing Twelve Months Ending 2022-03
Book Value / Share 20.21 Trailing Twelve Months Ending 2022-03
Price to Book Value 3.45 Calculated using Price: 69.65
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.33 Cr. 3,300,000 Shares
FaceValue 10
Company Profile
They manufacture and undertake job work of coating of various substrates like non woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with adhesive. They are engaged into the business of ethical marketing and distribution of Surgical Disposable, Haemostat, Medical Devices, Urology Equipments, Surgery Equipments, Orthopedic/Physiotherapy equipments, Blood Banking Equipments and other such Surgical Equipments in India. They also undertake job work of coating of various substrates like non woven fabrics, PU films, cotton fabrics, taffeta silk fabrics with adhesive. They offer a gamut of products, which includes Absorbable Gelatin Surgical Sponge, Surgipore Tape, Surgipore Tape (Silk), Cushions for ESWL-VI Shock Wave Hand, Dressing Post-Op Medicated, Dresiing Silicon Gel, Micrporus Surgical Foam Tape, Fleece Fabric, and Double Side Adhesive tapes.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
1 Month
+69.46%
3 Month
+103.36%
6 Month
+103.36%
1 Year
+102.77%
2 Year
+104.85%
5 Year
+131.40%
10 Year
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 2.45 2.82 6.13 6.26 1.98 1.99 1.78 1.92 3.28
Return on Capital Employed (%) 6.43 7.69 11.39 10.63 5.20 3.86 3.42 3.62 4.28
Return on Assets (%) 0.46 0.44 1.79 2.57 1.02 1.19 1.14 1.33 2.26

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 1 1 1 3 4 6 6 6 6 7
Non Curr. Liab. 2 2 2 1 1 1 1 1 1 1
Curr. Liab. 1 4 4 4 4 3 3 2 2 2
Minority Int.
Equity & Liab. 5 7 7 8 9 10 11 9 9 10
Non Curr. Assets 2 3 2 2 3 2 2 2 2 1
Curr. Assets 3 4 5 6 6 8 8 7 8 8
Misc. Exp. not W/O
Total Assets 5 7 7 8 9 10 11 9 9 10

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Net Sales 6 8 9 8 8 7 10 10 8 10
Other Income 0 0 0 0 0 0 0 0 0
Total Income 6 8 9 8 8 8 10 10 8 10
Total Expenditure -6 -7 -8 -8 -7 -7 -10 -10 -7 -10
PBIDT 0 1 1 1 1 1 1 1 1 1
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 0 0 0 0
Adjusted EPS 1 0 0 1 1 0 0 0 0 1

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 0 1 0 1 -2 1 -1 1 0
Cash Fr. Inv. -1 -2 0 0 -1 0 0 0 0 0
Cash Fr. Finan. 1 2 -1 1 0 2 -1 0 0 0
Net Change 0 0 0 1 0 0 0 -1 0 0
Cash & Cash Eqvt 0 0 0 1 1 2 1 0 1 0

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 74.42 74.42 74.42 74.42 74.42 74.42 74.42 74.42 74.42
Public 25.58 25.58 25.58 25.58 25.58 25.58 25.58 25.58 25.58
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 09 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Pursuant to Regulations 74(5) of SEBI (Depositories and Participants) Regulations 2018 please find enclosed herewith certificate received from KFIN Technologies Limited Registrar & Share Transfer Agent of the company for the quarter ended 31st December 2022.
Mon, 09 Jan 2023
Non-Applicability Of Report On Corporate Governance Pursuant To Regulation 27 (2) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015
As per Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 The compliance with the corporate governance provisions as specified in regulations 17 17A 18 19 20 21 22 23 24 24A 25 26 27 and clauses (b) to (i) and (t) of sub-regulation (2) of regulation 46 and para C D and E of Schedule V shall not apply in respect of a listed entity which has listed its specified securities on the SME Exchange.As the Company has listed its shares on BSE SME Platform so the above-mentioned provision will not be applicable to the Company and hence the Company is not required to disclose Report on Corporate Governance pursuant to Regulation 27 (2) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 for the Quarter ended 31st December 2022.
Tue, 20 Dec 2022
Submission Of Standalone Unaudited Assets And Liabilities For The Half Year Ended 30Th September 2022- Revised Submission
Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we have submitted copy of the Unaudited Standalone Financial Results of the Company for the half year ended 30th September 2022 along with notes and Limited review report. Vide e-mail dated 19th December 2022 BSE brought to our notice one discrepancies in the aforesaid submission of financial results: Discrepancy: 1. Standalone Results - Bifurcation of Trade payble not Provided as per Accounting standard Division I Format for Half Year Ended - September 2022.

Hence we are refurnishing the revised "Standalone unaudited Assets and Liabilities for the half year ended 30th September 2022.

Technical Scans View Details >>

No Scans Found

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 252,338.06 1,051.70 +0.8%
Divi's Laboratories Ltd. 89,367.34 3,366.40 -0.6%
Cipla Ltd. 83,741.18 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. 72,084.75 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. 61,094.10 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. 52,291.51 1,545.05 +0.5%
Abbott India Ltd. 44,555.01 20,967.75 -1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 61.43 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-09 29.89 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-12 31.74 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.79 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.76 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.93 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-09 50.53 20,967.75 -1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.75 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-09 7.37 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-12 3.69 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.28 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.21 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.20 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-09 16.41 20,967.75 -1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 0.00 20,967.75 -1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 29.95 20,967.75 -1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 29.95 20,967.75 -1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,967.75 -1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 798.70 20,967.75 -1.2%

FAQ's On KMS Medisurgi Ltd.

What is KMS Medisurgi share price?

Can I buy KMS Medisurgi shares now?

What is the Market Cap of KMS Medisurgi?

What are the key metrics to analyse KMS Medisurgi?

What is the 52 Week High and Low of KMS Medisurgi?